Spectrum selects new vice president of research
Sandra A. Rempel, previously a cancer research executive at Henry Ford Hospital, is now Spectrum Health’s new vice president of research.
“We are very pleased to welcome Dr. Rempel,” said Matt Van Vranken, executive vice president, Spectrum Health Delivery System. “Sandra’s leadership and experience will be invaluable as we create and build an academic framework within the strong alliance established by Spectrum Health, Van Andel Research Institute and Michigan State University College of Human Medicine.”
The new vice president will oversee all clinical, translational and basic research at Spectrum Health, including planning, recruiting, quality, compliance and support of all clinical research activities.
Rempel received her Ph.D. in molecular and cellular biology from the University of Calgary, Canada, and her bachelor’s degree in biochemistry from the University of Winnipeg. She also was a post-doctoral fellow at the Ludwig Institute for Cancer Research in San Diego.
Rempel most recently served as associate director of research for the Josephine Ford Cancer Center at Henry Ford Hospital. She also served as director of the Barbara Jane Levy Laboratory of Molecular Neuro-Oncology and as director of basic research for the Hermelin Brain Tumor Center at Henry Ford Hospital. She is an adjunct associate professor with the Department of Pharmacology at Wayne State University School of Medicine, and a member of the Tumor and Microenvironment Program at the Barbara Ann Karmanos Cancer Institute.
During her career, Rempel has received multiple honors and awards for her extensive expertise in research. She has published more than 50 peer-reviewed papers, a number of book chapters and has led numerous presentations at national and international meetings.